Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50,740 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial.
Sha H, Tong F, Ni J, Sun Y, Zhu Y, Qi L, Li X, Li W, Yang Y, Gu Q, Zhang X, Wang X, Zhu C, Chen D, Liu B, Du J. Sha H, et al. Among authors: zhu y. Signal Transduct Target Ther. 2024 Jun 7;9(1):143. doi: 10.1038/s41392-024-01857-6. Signal Transduct Target Ther. 2024. PMID: 38844468 Clinical Trial.
Clinicopathological Features and Long-Term Prognostic Role of Human Epidermal Growth Factor Receptor-2 Low Expression in Chinese Patients with Early Breast Cancer: A Single-Institution Study.
Kong ZQ, Liu LQ, Huang Q, Wang YT, Li JJ, Zhang Z, Wang XX, Liu CL, Zhang YD, Shao JK, Zhu YM, Chen YM, Liu M, Zhao WH. Kong ZQ, et al. Among authors: zhu ym. Biomed Environ Sci. 2024 May 20;37(5):457-470. doi: 10.3967/bes2024.014. Biomed Environ Sci. 2024. PMID: 38843919
50,740 results
You have reached the last available page of results. Please see the User Guide for more information.